HeraMED Limited (1I4) - Total Liabilities
Based on the latest financial reports, HeraMED Limited (1I4) has total liabilities worth €559.96K EUR (≈ $654.65K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore HeraMED Limited long-term investment intensity to see how much of total assets are deployed in long-term investments.
HeraMED Limited - Total Liabilities Trend (2018–2025)
This chart illustrates how HeraMED Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is HeraMED Limited's balance sheet.
HeraMED Limited Competitors by Total Liabilities
The table below lists competitors of HeraMED Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AS Pro Kapital Grupp
F:17E
|
Germany | €55.04 Million |
|
Hankukpackage Co. Ltd
KQ:037230
|
Korea | ₩104.75 Billion |
|
HPP Holdings Bhd
KLSE:0228
|
Malaysia | RM34.38 Million |
|
TT Vision Holdings Berhad
KLSE:0272
|
Malaysia | RM30.83 Million |
|
Bonava AB (publ)
ST:BONAV-A
|
Sweden | Skr9.17 Billion |
|
Senetas Corporation Ltd
AU:SEN
|
Australia | AU$16.74 Million |
|
Venteny Fortuna International
JK:VTNY
|
Indonesia | Rp958.76 Billion |
|
Touch Ventures Ltd
AU:TVL
|
Australia | AU$202.00K |
Liability Composition Analysis (2018–2025)
This chart breaks down HeraMED Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is HeraMED Limited's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.60 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how HeraMED Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for HeraMED Limited (2018–2025)
The table below shows the annual total liabilities of HeraMED Limited from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €559.96K ≈ $654.65K |
-67.31% |
| 2024-12-31 | €1.71 Million ≈ $2.00 Million |
-36.90% |
| 2023-12-31 | €2.71 Million ≈ $3.17 Million |
+42.61% |
| 2022-12-31 | €1.90 Million ≈ $2.23 Million |
-59.45% |
| 2021-12-31 | €4.70 Million ≈ $5.49 Million |
+202.34% |
| 2020-12-31 | €1.55 Million ≈ $1.82 Million |
-10.53% |
| 2019-12-31 | €1.74 Million ≈ $2.03 Million |
+3.38% |
| 2018-12-31 | €1.68 Million ≈ $1.96 Million |
-- |
About HeraMED Limited
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more effic… Read more